Sio Gene Therapies Inc. Common Stock
SIOX
SIOX was delisted on the 22nd of March, 2023.
70 hedge funds and large institutions have $454M invested in Sio Gene Therapies Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 21 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
1% less funds holding
Funds holding: 71 → 70 (-1)
20% less call options, than puts
Call options by funds: $1.73M | Put options by funds: $2.15M
65% less capital invested
Capital invested by funds: $1.29B → $454M (-$837M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$13.6M |
| 2 |
JP Morgan Chase
New York
|
+$5.78M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.67M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
+$3.53M |
| 5 |
AFG
American Financial Group
Cincinnati,
Ohio
|
+$2.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$969M |
| 2 |
DM
Deerfield Management
New York
|
-$6.26M |
| 3 |
D.E. Shaw & Co
New York
|
-$5.76M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.49M |
| 5 |
Capstone Investment Advisors
New York
|
-$3.23M |
SIOX Hedge Fund Activity: Q4 2015 in Review
70 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q4 2015, worth a combined $454M — down 65% from $1.29B a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of SIOX and 20 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 27 added.
The largest buyer was Janus Henderson Investors US, adding an estimated $13.6M. The largest seller was QVT Financial, exiting entirely with an estimated $969M sold.
- 70 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q4 2015, down from 71 in Q3 2015.
- Funds reported $454M of Sio Gene Therapies Inc. Common Stock stock for Q4 2015, down 65% quarter-over-quarter.
- 20 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q4 2015 and 21 closed out, a net change of -1 holder.
- The largest Sio Gene Therapies Inc. Common Stock buyer in Q4 2015 was Janus Henderson Investors US, an estimated $13.6M added.
- The largest Sio Gene Therapies Inc. Common Stock seller in Q4 2015 was QVT Financial, an estimated $969M sold.
Based on aggregated 13F filings for Q4 2015.